EN DE

American Medical Technologies Inc (ADLI) Fair Value & Analysis

Healthcare · US · Market cap $26.0K

AM American Medical Technologies Inc logo American Medical Technologies Inc ADLI · US
Price$0.0001
Fair Value$0.0001
Upside+0.0%
Quality42/100
Watch American Medical Technologies Inc for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 7.8% net margin
Negative equity (buybacks among others)
Mixed vs. peers (4/9)
Narrow moat 13/100
Evidence: Low Range $0.0001 – $0.0001 Share as image

Fair value as of: Aug 16, 2026

From 5 valuation models · updated 2 days ago

Below-average quality, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$0.0150 $0.0001 Fair Value $0.0001 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 16, 2026.

How to read this chart

60‑month range $0.0001 – $0.0150 · the $0.0001 price screens below the $0.0001 fair value. Dashed = 300-day average. As of Aug 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

American Medical Technologies Inc (ADLI) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, American Medical Technologies Inc generated revenue of $2.5M at a net margin of 7.8%. Revenue declined 19.2% year over year. Fundamentals as of Aug 16, 2026

The share trades near its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at 0%, ADLI screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth-Adj P/E $0.0001 $0.0001 $0.0001 68
P/E Multiple $0.0001 $0.0001 $0.0001 63
P/S Multiple $0.0001 $0.0001 $0.0001 58
All 5 models by family
DCF Models
Owner Earnings $0.0001 $0.0001 $0.0001 31
Earnings-Based
Graham-Dodd $0.0001 $0.0001 $0.0001 54
Multiples
P/E Multiple $0.0001 $0.0001 $0.0001 63
P/S Multiple $0.0001 $0.0001 $0.0001 58
Growth Earnings
Growth-Adj P/E $0.0001 $0.0001 $0.0001 68

Widest divergence: DCF Models ($0.0001) versus DCF Models ($0.0001). Highest evidence: Growth-Adj P/E (68).

Notify me when ADLI reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $2.5M
Revenue growth (YoY) -19.2%
Net margin 7.8%
Operating margin -22.5%
EPS growth (YoY) -6.0%

Figures from reported company fundamentals · as of Aug 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 42/100

Of which business quality 40 · Market factors (momentum, volatility) 56

Profitability 79
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 4
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 33
Distance to the 52-week high (market factor)

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

American Medical Technologies Inc. develops, manufactures, and markets dental related equipment. The company's products include air abrasive systems, high speed curing lights, and intra-oral video cameras. It serves dentists worldwide.

Full company description

American Medical Technologies Inc. develops, manufactures, and markets dental related equipment. The company's products include air abrasive systems, high speed curing lights, and intra-oral video cameras. It serves dentists worldwide. The company provides sales and technical support through a network of authorized distributors and dealers in North America, as well as through independent equipment representatives. American Medical Technologies Inc. was formerly known as American Dental Technologies Inc. and changed its name to American Medical Technologies Inc. in July 2000. The company was founded in 1986 and is based in Corpus Christi, Texas.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2004 – FY2008 · reported fiscal years

American Medical Technologies Inc reported revenue of $2.5M in FY2008 versus $2.3M in FY2004, a compound +2.7%/yr. Reported net income was $194K in FY2008, compounding +60.9%/yr from FY2004.

Growth Quality 6/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2008)
$2.5M
Latest YoY
−21.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−3.5%
Avg. growth/yr (8Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−22.8%
Revenue +2.7%/yr
FY04 $2.3M
FY05 $2.2M
FY06 $2.8M
FY07 $3.2M
FY08 $2.5M
Net income +60.9%/yr
FY04 $29.0K
FY05 −$1.5M
FY06 −$1.4M
FY07 −$927K
FY08 $194K

Watch ADLI: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "American Medical Technologies Inc Fair Value". https://www.fairvalue-calculator.com/stock/ADLI

Peer Group

Medical Instruments & Supplies · 204 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 42 · Bottom 25%
Fair Value upside +0% · Above median
Return on assets -17% · Bottom 25%
Net margin (TTM) 8% · Above median
Operating margin (TTM) -22% · Bottom 25%
Revenue growth -19% · Bottom 25%

Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper

P/S (TTM) 0.01× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 33 · sector 0
FUTURE 0 · sector 27
PAST 0 · sector 25
HEALTH 100 · sector 96
DIVIDEND 0 · sector 37

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 16, 2026).

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $401.27 $150.04 -63%
EssilorLuxottica Société anonyme 1EL €164.40 €68.55 -58%
Medline Inc MDLN $35.50 $30.15 -15%
Becton, Dickinson and Company BDX $181.41 $100.46 -45%
Alcon Inc ALC $73.58 $39.78 -46%
ResMed Inc RMD $226.00 $187.89 -17%
West Pharmaceutical Services, Inc WST $352.29 $141.58 -60%
Sartorius Stedim Biotech S.A DIM €180.30 €48.88 -73%
Coloplast A/S COLOB kr 429.70 kr 382.22 -11%
Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 ¥77.48 ¥27.22 -65%

Compare American Medical Technologies Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is American Medical Technologies Inc (ADLI) overvalued or undervalued?
As of Aug 16, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001, about +0% (fairly valued).
What is the fair value of ADLI?
Our model-based fair value for American Medical Technologies Inc is $0.0001 (as of Aug 16, 2026), built from audited fundamentals. The current price is $0.0001.
What is the quality score of ADLI?
American Medical Technologies Inc has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of American Medical Technologies Inc (ADLI)?
American Medical Technologies Inc reported trailing-twelve-month revenue of about $2.5M (latest available figure, as of Aug 16, 2026).
What is the net profit margin of ADLI?
The net profit margin of American Medical Technologies Inc is about 7.8%, meaning it keeps roughly 7.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track American Medical Technologies Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.